A 5-day outpatient regimen of azacitidine is effective and well tolerated in patients with acute myeloid leukemia unsuitable for intensive chemotherapy

Leuk Lymphoma. 2014 Dec;55(12):2950-1. doi: 10.3109/10428194.2014.904512. Epub 2014 Apr 22.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antimetabolites, Antineoplastic / therapeutic use*
  • Azacitidine / therapeutic use*
  • Female
  • Frail Elderly*
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy*
  • Male

Substances

  • Antimetabolites, Antineoplastic
  • Azacitidine